In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Co-Lead Class Counsel Elizabeth Pritzker and Pritzker Levine represent a certified class of end-payer plaintiffs in a nationwide RICO and multi-state antitrust class action alleging that Mylan NV and Pfizer, Inc., the seller and manufacturer of the life-saving EpiPen, respectively, engaged in an unlawful scheme to sharply increase the price of the device while at the same time stifling competition seeking to enter the market. Plaintiffs reached settlements with both defendants for a total recovery of $609 million for class members.